Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
VJOncology had the opportunity to attend to the European Society for Medical Oncology (ESMO) 2022 Congress which was held in Paris, France and virtually between the 9-13th September. Leading experts in oncology presented face-to-face on the latest developments across the field, including updates from CheckMate 914, monarcHER, and more. Stay tuned for the latest coverage of ESMO 2022 with VJOncology where we were live in Paris!
🎥@BenWestphalen of @LMU_Muenchen highlights the transformative impact of KRAS inhibitors, like sotorasib and panitumumab, across oncology, with significant advancements discussed at #ESMO23:
European Society for Medical Oncology Congress 2022
01 September 2022 | Paris, France
VJOncology had the opportunity to attend to the European Society for Medical Oncology (ESMO) 2022 Congress which was held in Paris, France and virtually between the 9-13th September. Leading experts in oncology presented face-to-face on the latest developments across the field, including updates from CheckMate 914, monarcHER, and more. Stay tuned for the latest coverage of ESMO 2022 with VJOncology where we were live in Paris!
🎥@BenWestphalen of @LMU_Muenchen highlights the transformative impact of KRAS inhibitors, like sotorasib and panitumumab, across oncology, with significant advancements discussed at #ESMO23:
The European Society for Medical Oncology (ESMO) 2021 annual meeting has showcased developments, ground-breaking data, and updates on potential new treatments for cancer. View our video interviews with leading experts!